Yasser Hazzaa
Yasser Hazzaa is a life sciences finance leader with 25+ years of experience in value creation, financial transformation, and board-level stewardship.
Through YH CFO Consulting, he partners with biotech and growth-stage leadership teams to strengthen governance and decision quality through clear performance narratives, disciplined forecasting, and reporting built for boardrooms, financings, and diligence.
His approach is outcomes-driven: tighter runway visibility, fewer financial surprises, and finance operations built to anticipate the demands of scaling businesses. He is known for stepping in quickly, identifying what is broken, and building the tools, reporting cadence, and analysis needed to restore control and decision speed.
Trusted Experience Across
Primary Areas of Strategic Focus
Governance and Board Advisory
- Making strategic tradeoffs explicit through stronger board packs and decision materials.
- Institutionalizing risk governance and board-ready reporting.
- Building the discipline required for credibility and transparency with all stakeholders.
Capital Strategy and Liquidity Stewardship
- Building scenario planning and resource prioritization frameworks.
- Implementing working capital discipline and liquidity strategies.
- Designing KPI operating cadences that improve capital efficiency.
FP&A and Performance Transformation
- Transitioning organizations to driver-based forecasts that connect spending to business drivers.
- Deploying automated KPI dashboards for real-time performance visibility.
- Strengthening unit economics and profitability through targeted operational improvements.
Investor and Stakeholder Narratives
- Connecting operational results to guidance and milestones through clear executive messaging.
- Ensuring data room readiness and providing diligence support.
- Developing board-ready materials for financings, partnerships, and capital decisions.
Career highlights
Founder and Principal, YH CFO Consulting | Mar 2026 to Present
At MannKind Corporation (Nasdaq: MNKD), he served as Vice President of Finance and Treasurer from 2017 to 2025, leading FP&A, treasury, capital allocation, procurement, executive dashboards, and board materials.
At Bristol Myers Squibb, he built a 20-year track record of finance leadership across the U.S., Europe, and the Middle East, leading long-range forecasting and FP&A that supported product launches, lifecycle management, strategic partnerships, and acquisitions.
He served in private company board roles at TesoRx Pharma and Lipac Oncology.
Credentials
MBA, International Business (with distinction), Maastricht School of Management, Netherlands.
BSc, Electrical Engineering, Ain Shams University, Cairo, Egypt.
CPA exams passed (State of Maine) and Professional Ethics exam passed (State of California).
Professional Community
Professional affiliations include FEI Los Angeles and CFO Focus (C-Suite Focus).
He has also been featured as a special guest at BioMedLey.
Ready to connect?
If you need board-ready finance leadership to improve decision quality, reporting rigor, and capital discipline, let's discuss your priorities.
Schedule a 30-Min Executive Call